Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Daily Persistent Headache (NDPH): Biomarker Study and Therapy in Children and Adolescents

NCT06018025 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06018025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Daily Persistent Headache (NDPH): Biomarker Study and Therapy in Children and Adolescents
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
April 15, 2024
Completion date
May 29, 2025
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

new persistent daily headache